Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Major trends in ACS care | Valve oversizing & PVL | Comparing balloon-expandable TAVR valves | AI tracks long-term heart risks
Tuesday, April 22, 2025
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

Tracking major trends and clinical research in acute coronary syndrome care

Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients.

READ MORE >
Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai, explains what he sees as the top recent trials impacting acute coronary syndrome care (ACS).
Share on Twitter Share on Facebook Share on Linkedin

Tracking major trends and clinical research in acute coronary syndrome care

Share on Twitter Share on Facebook Share on Linkedin
Deepak L. Bhatt, MD, MPH, MBA, Director of Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine at the Icahn School of Medicine at Mount Sinai, explains what he sees as the top recent trials impacting acute coronary syndrome care (ACS).
Deepak Bhatt, MD, detailed several recent clinical trials that could reshape the way clinicians manage acute coronary syndrome (ACS) patients.
READ MORE >

Oversizing reduces PVL when implanting Medtronic’s newer self-expanding TAVR valves

Paravalvular leak has been shown to impact patient outcomes after TAVR. Higher degrees of valve oversizing, however, can reduce the risk of post-treatment PVL without increasing the odds of adverse outcomes.

READ MORE >
Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
Share on Twitter Share on Facebook Share on Linkedin

Oversizing reduces PVL when implanting Medtronic’s newer self-expanding TAVR valves

Share on Twitter Share on Facebook Share on Linkedin
Medtronic Evolut FX TAVR valve. Medtronic has received an additional CE mark approval for its Evolut Pro+ and FX transcatheter aortic valve replacement (TAVR) valves; they can now be used for redo TAVR in addition to traditional TAVR procedures.
Paravalvular leak has been shown to impact patient outcomes after TAVR. Higher degrees of valve oversizing, however, can reduce the risk of post-treatment PVL without increasing the odds of adverse outcomes.
READ MORE >

Myval TAVR valve non-inferior to Sapien 3 after 1 year—pacemaker implants the biggest difference

India-based Meril Life Sciences has been manufacturing its Myval transcatheter heart valves for years, but the technology has not yet gained FDA approval. This latest head-to-head comparison included data from more than 1,000 TAVR patients.

READ MORE >
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
Share on Twitter Share on Facebook Share on Linkedin

Myval TAVR valve non-inferior to Sapien 3 after 1 year—pacemaker implants the biggest difference

Share on Twitter Share on Facebook Share on Linkedin
Meril Life Sciences, an India-based medical device company founded in 2006, developed the Myval TAVR valve. The Myval transcatheter heart valve (THV) is non-inferior to the Sapien 3 THV after one year, according to new transcatheter aortic valve replacement (TAVR) data published in The Lancet.
India-based Meril Life Sciences has been manufacturing its Myval transcatheter heart valves for years, but the technology has not yet gained FDA approval. This latest head-to-head comparison included data from more than 1,000 TAVR patients.
READ MORE >

AI-powered risk model evaluates long-term risk of coronary artery disease

The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available. 

READ MORE >
artificial intelligence AI heart cardiology
Share on Twitter Share on Facebook Share on Linkedin

AI-powered risk model evaluates long-term risk of coronary artery disease

Share on Twitter Share on Facebook Share on Linkedin
artificial intelligence AI heart cardiology
The advanced machine learning model tracks more than 50 different factors to make its predictions. It has already been found to be more accurate than popular prediction methods for heart disease that are currently available. 
READ MORE >

Featured Articles

Family of heart patient who died awarded $45M after suing health system for negligence

The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.

READ MORE >
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
Share on Twitter Share on Facebook Share on Linkedin

Family of heart patient who died awarded $45M after suing health system for negligence

Share on Twitter Share on Facebook Share on Linkedin
American Heart Association and Joint Commission launch new Comprehensive Heart Attack Center certification.
The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.
READ MORE >

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits

Researchers tracked nearly 1,000 SAVR patients, presenting eight-year data at the Heart Valve Society’s annual meeting in Cairo, Egypt. 

READ MORE >
Edwards Lifesciences INSPIRIS RESILIA Aortic Valve
Share on Twitter Share on Facebook Share on Linkedin

Resilia tissue developed by Edwards Lifesciences linked to long-term benefits

Share on Twitter Share on Facebook Share on Linkedin
Edwards Lifesciences INSPIRIS RESILIA Aortic Valve
Researchers tracked nearly 1,000 SAVR patients, presenting eight-year data at the Heart Valve Society’s annual meeting in Cairo, Egypt. 
READ MORE >

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.

READ MORE >
Conavi Medical’s Novasight Hybrid System catheter
Share on Twitter Share on Facebook Share on Linkedin

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Share on Twitter Share on Facebook Share on Linkedin
Conavi Medical’s Novasight Hybrid System catheter
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
READ MORE >

AI-based coronary plaque evaluations highlight elevated heart risks in women

“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.

READ MORE >
Gudrun Feuchtner, MD, MBA, HCM, assistant professor, cardiovascular imaging, Medical University Innsbruck, Department Radiology, explains how artificial intelligence-based quantitative computed tomography (AI QCT) coronary plaque features are better able to predict risk in women, according the the results of the late-breaking CONFIRM2 study at ACC 2025.
Share on Twitter Share on Facebook Share on Linkedin

AI-based coronary plaque evaluations highlight elevated heart risks in women

Share on Twitter Share on Facebook Share on Linkedin
Gudrun Feuchtner, MD, MBA, HCM, assistant professor, cardiovascular imaging, Medical University Innsbruck, Department Radiology, explains how artificial intelligence-based quantitative computed tomography (AI QCT) coronary plaque features are better able to predict risk in women, according the the results of the late-breaking CONFIRM2 study at ACC 2025.
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
READ MORE >

In Case You Missed It

Shockwave Medical testing new-look IVL technology on challenging coronary lesions

Care teams throughout the U.S. and U.K. are now exploring the safety and effectiveness of using Shockwave Medical's new Javelin IVL catheters to treat challenging, difficult-to-cross coronary lesions. 

READ MORE >
Shockwave Medical IVL
Share on Twitter Share on Facebook Share on Linkedin

Shockwave Medical testing new-look IVL technology on challenging coronary lesions

Share on Twitter Share on Facebook Share on Linkedin
Shockwave Medical IVL
Care teams throughout the U.S. and U.K. are now exploring the safety and effectiveness of using Shockwave Medical's new Javelin IVL catheters to treat challenging, difficult-to-cross coronary lesions. 
READ MORE >

Starfish-shaped heart monitors use AI to deliver accurate results

Researchers have taken inspiration from starfish to design an AI-powered wearable device that delivers accurate real-time heart monitoring.

READ MORE >
starfish heart monitor
Share on Twitter Share on Facebook Share on Linkedin

Starfish-shaped heart monitors use AI to deliver accurate results

Share on Twitter Share on Facebook Share on Linkedin
starfish heart monitor
Researchers have taken inspiration from starfish to design an AI-powered wearable device that delivers accurate real-time heart monitoring.
READ MORE >

CMS proposes Medicare coverage for T-TEER

CMS has proposed covering tricuspid TEER for patients who present with symptomatic tricuspid regurgitation despite optimal medical therapy. The agency still has questions about the available data, however, and is seeking public comments as it makes its final decision.

READ MORE >
Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).
Share on Twitter Share on Facebook Share on Linkedin

CMS proposes Medicare coverage for T-TEER

Share on Twitter Share on Facebook Share on Linkedin
Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its TriClip transcatheter edge-to-edge repair (TEER) system designed to treat tricuspid regurgitation (TR).
CMS has proposed covering tricuspid TEER for patients who present with symptomatic tricuspid regurgitation despite optimal medical therapy. The agency still has questions about the available data, however, and is seeking public comments as it makes its final decision.
READ MORE >

In Other News

Hawaii’s largest hospital alerts staff after imaging backlog reaches 8,000 exams

The Aloha State is reportedly facing challenges with hiring radiologists and radiologic technologists to meet heavy demand for medical imaging. 

READ MORE >
Hawaii Maui island paradise
Share on Twitter Share on Facebook Share on Linkedin

Hawaii’s largest hospital alerts staff after imaging backlog reaches 8,000 exams

Share on Twitter Share on Facebook Share on Linkedin
Hawaii Maui island paradise
The Aloha State is reportedly facing challenges with hiring radiologists and radiologic technologists to meet heavy demand for medical imaging. 
READ MORE >

Proposed HHS budget would close NINR, cut nursing programs

The American Nurses Association is warning that eliminating support for the training and research offered by the National Institute of Nursing Research could be devastating to the public, as many programs support specialties such as maternal and mental health. 

READ MORE >
AI in nursing
Share on Twitter Share on Facebook Share on Linkedin

Proposed HHS budget would close NINR, cut nursing programs

Share on Twitter Share on Facebook Share on Linkedin
AI in nursing
The American Nurses Association is warning that eliminating support for the training and research offered by the National Institute of Nursing Research could be devastating to the public, as many programs support specialties such as maternal and mental health. 
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Medtech giant makes big move | The world’s top hospitals for heart surgery | New CPT codes | PET vs. SPECT | TAVR tech recalled
AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme
Trimed Popup